Friday, October 31, 2014

Deals

Polyplus-transfection and Blue Sky BioServices Sign a Research and Commercial License Agreement

October 29, 2014 · Leave a Comment 

  Polyplus-transfection SA, a privately-held company developing innovative technologies for molecular and cellular biology, and Blue Sky BioServices, a contract research organization (CRO) providing Gene Through Screen services for the pharmaceutical and biotechnology R&D market, has announced a non-exclusive, research and commercial license agreement. Polyplus has granted Blue Sky BioServices a licence to use Polyethylenimine (PEI) for in vitro transfection applications. Blue Sky BioServices, has become the 17th sub-licensee, and the 4th CRO to acquire rights from Polyplus to use its... [Read the full story]

Deal News

Polyplus-transfection and Blue Sky BioServices Sign a Research and Commercial License Agreement

October 29, 2014 · Leave a Comment 

  Polyplus-transfection SA, a privately-held company developing innovative technologies for molecular and cellular biology, and Blue Sky BioServices, a contract research organization (CRO) providing Gene Through Screen services for the pharmaceutical and biotechnology R&D market, has announced a non-exclusive, research and commercial license agreement. Polyplus has granted Blue Sky BioServices a licence to use Polyethylenimine (PEI) for in vitro transfection applications. Blue Sky BioServices, has become the 17th sub-licensee, and the 4th CRO to acquire rights from Polyplus to use its... [Read the full story]

Legal

UF, BP settle long-running dispute, though impact to university remains unclear

August 9, 2014 · Leave a Comment 

  A partnership with British Petroleum that should have produced a stream of royalty revenues for the University of Florida for years has evaporated with the stroke of a pen, settling a two-year court battle over $30 million in disputed fees and royalties. The two sides in the intellectual property suit that BP brought against UF quietly reached a settlement agreement over the disputed licensing fees and royalties for a process invented by UF researcher Lonnie Ingram that converts wood pulp into ethanol. A federal judge dismissed the suit in December, reserving the right to bring both sides... [Read the full story]

Bio

Polyplus-transfection and Blue Sky BioServices Sign a Research and Commercial License Agreement

October 29, 2014 · Leave a Comment 

  Polyplus-transfection SA, a privately-held company developing innovative technologies for molecular and cellular biology, and Blue Sky BioServices, a contract research organization (CRO) providing Gene Through Screen services for the pharmaceutical and biotechnology R&D market, has announced a non-exclusive, research and commercial license agreement. Polyplus has granted Blue Sky BioServices a licence to use Polyethylenimine (PEI) for in vitro transfection applications. Blue Sky BioServices, has become the 17th sub-licensee, and the 4th CRO to acquire rights from Polyplus to use its... [Read the full story]

University Tech Transfer

The Texas A&M University System and XOMA License Innovative Manufacturing Technology

October 7, 2014 · Leave a Comment 

  COLLEGE STATION, Texas and BERKELEY, Calif., Oct. 6, 2014 (GLOBE NEWSWIRE) — The Texas A&M University System and XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and development of therapeutic antibodies, today announced that the Texas A&M University System agreed to a non-exclusive license for XOMA’s innovative design of a manufacturing facility. The patented technology relates to a flexible arrangement of mobile clean rooms (MCRs) within the manufacturing facility with each MCR providing a portable, self-contained environment that allows for drug development.... [Read the full story]

People

Boulder’s Innovation Center of the Rockies signs commercialization agreement with University of Wyoming

October 11, 2013 · Leave a Comment 

  The Innovation Center of the Rockies, a Boulder-based organization created to help research institutions commercialize technology, has entered into an agreement with the University of Wyoming, officials announced Tuesday. Financial terms of the agreement were not disclosed. The University of Wyoming is the first commercialization partner outside the state of Colorado for the nonprofit Innovation Center of the Rockies, which has inked similar deals with the University of Colorado, Colorado School of Mines, Colorado State University and the University of Denver. “I think that we’ve... [Read the full story]

Deals

Polyplus-transfection and Blue Sky BioServices Sign a Research and Commercial License Agreement

  Polyplus-transfection SA, a privately-held company developing innovative technologies for molecular and cellular biology, and Blue Sky BioServices, a contract research organization (CRO) providing Gene Through Screen services for the pharmaceutical and biotechnology R&D market, has announced a non-exclusive, research and commercial license... Read more of this article


Tipping Point Gaming (TPG) Announces Exclusive License Agreement with WMS

  LAS VEGAS, Oct. 29, 2014 /PRNewswire/ — Tipping Point Gaming (TPG), a pioneer and leading developer of “Picture-In-Picture” (PIP) style systems and applications for the casino gaming industry has announced today that it has signed an exclusive license agreement with WMS Gaming Inc., a wholly owned subsidiary of Scientific Games... Read more of this article


Imprimis Pharmaceuticals Enters into License Agreement for Patented Urology Formulation

  SAN DIEGO, Oct. 29, 2014 /PRNewswire/ – Imprimis Pharmaceuticals, Inc. (Nasdaq: IMMY) today announced that it has entered into a license agreement, under which Imprimis acquired the US rights to commercially compound a patented combination of alkalized lidocaine and heparin from Urigen Pharmaceuticals, Inc.  Physicians in the US and abroad... Read more of this article


IpVenture Announces Sale of Webvan Patent Portfolio

  LOS ALTOS, Calif., Oct. 29, 2014 /PRNewswire/ – IpVenture, Inc., a patent development and monetization firm, announced today that it has sold the Webvan patent portfolio for an undisclosed sum to a global conglomerate based in Asia. DIAMOND IN THE ROUGH When founded in 1999 during the height of the dot-com bubble, Webvan grew at lightning... Read more of this article


WiLAN Subsidiary Enters into Patent Agreement with ROHM Co., Ltd.

  OTTAWA, CANADA–(Marketwired – Oct. 29, 2014) - Top intellectual property licensing company, WiLAN (TSX:WIN) (NASDAQ:WILN), today announced that a wholly-owned subsidiary of the company has entered into a patent assignment agreement with ROHM Co., Ltd. (“ROHM”) under which WiLAN’s subsidiary is to receive full ownership... Read more of this article


RocTool wins global licensing agreement with Flextronics

  RocTool (Le Bourget du Lac, France), specialist in the design and development of technologies for rapid molding of composites and plastics, reported on Oct. 14 that it has signed a global license agreement with Flextronics (Singapore), a leading provider of global end-to-end supply chain solutions including designing, manufacturing, shipping... Read more of this article


U of Edinburgh Licenses Genotyping Technology from KeyGene

  KeyGene announces today it entered into a licence agreement with the University of Edinburgh in the field of Sequence-Based Genotyping (SBG). With this agreement, the University of Edinburgh obtains a non-exclusive licence for the use and application of KeyGene’s patented SBG technology including RAD-Seq (Restriction-site Associated DNA Sequencing)... Read more of this article


Mersana and Takeda Enter Commercial License Agreement

  CAMBRIDGE, Mass., October 27, 2014 – Mersana Therapeutics, announced today that Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), has exercised an option to license commercial rights for its first novel Fleximer® antibody-drug conjugate (ADC) developed under their collaboration... Read more of this article


Clontech Laboratories Inc. Licenses From The Broad Institute

  Mountain View, CA—October 27, 2014—Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced that they have entered into a non-exclusive license agreement with the Broad Institute to access intellectual property related to the CRISPR/Cas9 gene editing system. “Clontech is pleased to be able to provide... Read more of this article


Lomiko Signs Licensing Agreement to Produce and Supply Power Converter Systems

  Lomiko Metals Inc. (“Lomiko”) (TSX VENTURE:LMR)(PINKSHEETS:LMRMF)(FRANKFURT:DH8B) and its 100% owned subsidiary Lomiko Technologies Inc. are pleased to announce an agreement to license from Megahertz Power Systems Ltd. (“Megahertz”) rights to manufacture and sell three (3) power converter system designs (“Licensed... Read more of this article


More Posts From Deals

Legal

UF, BP settle long-running dispute, though impact to university remains unclear

  A partnership with British Petroleum that should have produced a stream of... 


InterDigital Announces Patent License Agreement With Samsung

  WILMINGTON, Del., June 3, 2014 (GLOBE NEWSWIRE) — InterDigital, Inc.... 


More Posts From Legal

University Tech Transfer

The Texas A&M University System and XOMA License Innovative Manufacturing Technology

  COLLEGE STATION, Texas and BERKELEY, Calif., Oct. 6, 2014 (GLOBE NEWSWIRE)... 


Meridian Bioscience and the University of Tennessee Research Foundation Enter into a License Agreement for Electrokinetic Sensor Technology

  CINCINNATI, Aug 06, 2014 (BUSINESS WIRE) — Meridian Bioscience, Inc.... 


More Posts From University Tech Transfer